Experience of combined topical therapy with methylprednisoloni aceponatis and «Bepanten Plus»® in treatment of adult patients with moderate and severe atopic dermatitis
Keyword(s):
Background. To estimate efficiency of combined therapy with methylprednisolone aceponatis and «Bepanten Plus»® in adult patients with moderate and severe atopic dermatitis. Methods. We examined 32 adult patients, who were treated with TGCS methylprednisolone aceponatis and «Bepanten Plus»®. The efficiency of therapy was estimated with index SCORAD, IGA and subjective patients assessment. For 15 of 32 patients swabs for bacterial isolation to estimate Staphylococcus aureus growth were taken from lesional skin before therapy and on the 14 th or 20 th days of treatment. Results. The аverage value of index SCORAD decreased after 15 days of therapy, Me 41,7 to Me 23,3 a point (p
Keyword(s):
2021 ◽
Vol 19
(1)
◽
pp. 53-64
Keyword(s):
Keyword(s):
2020 ◽
Vol 83
(6)
◽
pp. AB144
Keyword(s):
2020 ◽
Vol 34
(10)
◽
pp. 2168-2169
2017 ◽
Vol 76
(6)
◽
pp. AB20
◽
Keyword(s):